11801 results for "cancer rna-seq"

in 11.30 milliseconds.

• Reference epigenome KNIH004 mRNA-seq data generated from KEP study

  A KNIH004 mRNA-seq paired end data for islet cells

  Dataset EGAD00001002170

• Reference epigenome IPS05_X_NPC_smRNA-Seq data generated from KEP study

  A IPS05_X_NPC_smRNA-Seq single end data for Neural progenitor cells(Nestin)

  Dataset EGAD00001003505

• Reference epigenome IPS06_X_ENeuron_smRNA-Seq data generated from KEP study

  A IPS06_X_ENeuron_smRNA-Seq single end data for Early neuron cells(Tuj1)

  Dataset EGAD00001003506

• Reference epigenome KNIH006 miRNA-seq data generated from KEP study

  A KNIH006 miRNA-seq single end data for beta cells

  Dataset EGAD00001002765

• 4C-seq data of a primary AML with t(3;8)

  The viewpoints used in the 4C-seq data were either the EVI1 promoter or the MYC super-enhancer

  Dataset EGAD00001006818

• Reference epigenome Islet-derived-MSC04 mRNA-Seq data generated from KEP study

  Islet-derived-MSC04 mRNA-Seq paired end data

  Dataset EGAD00001007163

• Reference epigenome IPS-Fibroblast02 h3k27ac ChIP-Seq data generated from KEP study

  IPS-Fibroblast02 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007270

• Reference epigenome IPS-ENeuron02 h3k27ac ChIP-Seq data generated from KEP study

  IPS-ENeuron02 h3k27ac ChIP-Seq paired end data

  Dataset EGAD00001007298

• CATNON: IDH-mutant astroctyoma RNA FASTQ

  Raw fastq files obtained by RNA sequencing 138 IDH-mutant astrocytomas included in the CATNON trial. RNA was extracted from formalin-fixed paraffin-embedded (FFPE) tissue blocks using the RNeasy FFPE kit. RNA sequencing was performed on an Illumina NovaSeq 6000 (GenomeScan BV, Leiden, The Netherlands) with 150bp paired-end reads including UMI tags.

  Dataset EGAD50000000558

• single nuclei multiomics (ATAC-RNA) of KOLF2.1J human induced pluripotent stem cells-derived differentiated dopaminergic neurons

  We processed nuclei from hIPSCs differentiated optimized protocols for generating dopaminergic neurons. Cells differentiated with a first iteration were RNA and ATAC-sequenced, to understand our protocol caveats to address for optimization. Cells differentiated with a second protocol and in vivo were RNA-sequenced to validate the identities of our cells.

  Study EGAS50000001418